A delayed clinical trial actually boosted Bristol Myers Squibb’s stock.
Here’s why.
-
Bristol Myers’ stock rallied Wednesday as investors maintained high hopes
for Cobenfy as an Alzheimer’s treatment, even though the outcome of a
late-stage ...
44 minutes ago







Egypt's caretaker government faces a new crisis: what to do about thousands of documents that protesters seized
ReplyDeleteRead more: http://www.mcclatchydc.com/2011/03/07/109966/egypt-faces-new-turmoil-looted.html#ixzz1FzKOR8Ly